-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the team of Professor Ji Chunyan from the Department of Hematology of Qilu Hospital of Shandong University, the team of Professor Li Jingxin from the School of Basic Medicine of Shandong University, and the team of Professor Baobing Zhao from the School of Pharmacy of Shandong University jointly published the title "Inhibition of the m6A Reader IGF2BP2 as a Strategy against Leukemia, an authoritative journal in the field of hematology and tumor.
T-ALL is a malignant clonal disease of the hematopoietic system.
Professor Ji Chunyan's team has long been committed to basic and clinical research on leukemia, focusing on multidisciplinary integration, developing new technologies for precise diagnosis and treatment of leukemia, and focusing on translational applications.
Related Links: